Free tool
FAERS Monitor: Omnipred
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 017469 or its brand name (Omnipred, Prednisolone Acetate). Reports on generic versions are filed under their own applications.
Reports
8,432
Serious
3,975
47% of reports
Hospitalization
1,566
Death reported
454
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- treatment failure1,251
- drug ineffective768
- recalled product administered763
- no adverse event641
- off label use537
- eye pain473
- eye irritation314
- vision blurred282
- fatigue255
- headache239
- diarrhoea220
- condition aggravated209
- pain204
- ocular hyperaemia198
- pyrexia186
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 17 |
| 2005 | 31 |
| 2006 | 35 |
| 2007 | 70 |
| 2008 | 130 |
| 2009 | 51 |
| 2010 | 70 |
| 2011 | 70 |
| 2012 | 160 |
| 2013 | 93 |
| 2014 | 125 |
| 2015 | 243 |
| 2016 | 483 |
| 2017 | 280 |
| 2018 | 404 |
| 2019 | 471 |
| 2020 | 1,633 |
| 2021 | 432 |
| 2022 | 505 |
| 2023 | 588 |
| 2024 | 628 |
| 2025 | 663 |
| 2026 | 1,250 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,727 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| recalled product administeredSignal | 763 | 216.8 | 202.0 | 150,669 |
| treatment failureSignal | 1,251 | 38.2 | 36.3 | 44,811 |
| eye painSignal | 473 | 21.1 | 19.3 | 8,976 |
| eye irritationSignal | 314 | 13.7 | 12.3 | 3,667 |
| ocular hyperaemiaSignal | 198 | 10.4 | 9.1 | 1,679 |
| no adverse eventSignal | 641 | 8.9 | 8.2 | 4,480 |
| vision blurredSignal | 282 | 5.1 | 4.6 | 938 |
| condition aggravated | 209 | 1.7 | 1.5 | 62 |
| off label use | 537 | 1.5 | 1.4 | 102 |
| drug ineffective | 768 | 1.5 | 1.4 | 116 |
| pyrexia | 186 | 1.3 | 1.2 | 16 |
| headache | 239 | 1.0 | 0.8 | 1 |
| diarrhoea | 220 | 0.9 | 0.7 | 6 |
| pain | 204 | 0.8 | 0.7 | 7 |
| fatigue | 255 | 0.8 | 0.7 | 11 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.